Aruni Ghose, Director and Chief Executive Officer at Canprecise AI, Chief Medical Officer at Shiksak, shared a post by Ricky Frazer, Consultant Medical Oncologist at Velindre Cancer Centre, Deputy CEO of the Immuno-Oncology Clinical Network, Co-Founder of The Immunobuddies Podcast and Honorary Lecturer at Cardiff University on LinkedIn, adding:
“Cancer, immunotherapy, toxicity, service and innovation at its very best from my Pioneering boss at the Velindre Cancer Service, Velindre University NHS Trust, Velindre Cancer Centre Fundraising, Velindre Oncology Academy, Cardiff University / Prifysgol Caerdydd – Prof Ricky Frazer.”
Quoting Ricky Frazer‘s post:
“Delighted (and slightly surreal!) to be featured in the latest OnCoffee x CancerWorld episode – huge thanks to Vahe Grigoryan, OncoDaily for such an engaging and thought-provoking conversation.
We got into the realities of modern oncology – not just the excitement of immunotherapy, but the complexity that comes with it: toxicity, acute oncology, decision-making under pressure, and what patient-centred care actually looks like.
We also touched on something I care deeply about – how our own experiences shape us as clinicians, and why communication, honesty, and a bit of vulnerability matter just as much as any guideline.
Reflecting on it, absolutely none of this is ever a solo effort. I’m incredibly fortunate to work alongside and learn from some brilliant individuals teams and communities:
- The Immunobuddies Podcast – growing a global, practical, no-nonsense community around immunotherapy.
- Immuno-Oncology Clinical Network – Oncology Clinical Network (IOCN) – driving collaboration and shared learning across borders.
- Velindre Cancer Service – where innovation meets real-world compassionate care every single day.
- Cardiff University / Prifysgol Caerdydd – leading amazing research and helping shape the next generation of oncology leaders.
I’d also like to shine a light on two incredible charities making a real difference for patients, helping to ensure people in Wales can access the latest advances in immunotherapy and beyond.
If you’re interested in where cancer care and immunotherapy is heading – and how we make it work in practice, not just on paper – I’d love you to take a listen.”
Other articles about Immunotherapy on OncoDaily.